Attend our Digital Sessions
Atomwise, Inc. will be presenting at this year's virtual BIO International Convention, June 8-12, 2020. Join our on demand events to hear Dr. Abraham Heifets give the Atomwise Company Presentation and speak as a guest panelist for the session Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development, hosted by Stemonix.
Atomwise, Inc.
Company Presentation
Organs-on-a-Chip and AI: Realizing Efficiencies in Drug Discovery and Development
Module: Next Generation Biotherapeutics
About the Speaker
Dr. Abraham Heifets is CEO and Co-Founder of Atomwise, where he and Co-Founder Dr. Izhar Wallach invented the use of deep convolutional neural networks for drug discovery.
Dr. Heifets was a Massey Fellow at the University of Toronto—a center for AI innovation—and a Fellow of the Ontario Brain Institute. His doctoral work applied machine learning and classical AI techniques to organic synthesis planning, a long-standing challenge in chemistry. His vision for the future of AI bringing better, safer and more potent drugs to patients was recently featured in the July 2019 Moonshot issue of Newsweek.
Dr. Heifets is a thought-leader on the use of AI for drug discovery and is an author on 24 papers, patents and patent applications. Dr. Heifets has presented his work to the U.S. GAO, the National Institutes of Health, the American Chemical Society, and the Association for the Advancement of Artificial Intelligence.